TEN63 THERAPEUTICS

Ten63 Therapeutics is a biotechnology company that uses its proprietary AI-driven platform, known as BEYOND, to develop therapeutics for cancer and other lethal diseases by targeting previously "undruggable" proteins and predicting and overcoming drug resistance.